L Sjögreen1, S Kiliaridis. 1. Mun-H-Center Orofacial Resource Centre for Rare Diseases and Department of Speech Pathology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Sweden. lotta.sjogreen@vgregion.se
Abstract
BACKGROUND: Earlier studies have shown that individuals with thalidomide embryopathy can have skeletal deformities, ear and eye aberrations, and facial palsy. This study aimed to survey the frequency and characteristics of facial palsy in this group of individuals. PARTICIPANTS: Thirty-one individuals with thalidomide embryopathy (age range, 45-47 years) and 25 healthy adults (age range, 41-56 years; mean age ± standard deviation, 49 ± 4.2 years). MAIN OUTCOME MEASURES: Voluntary facial movements, lip force and three-dimensional lip motion analysis. RESULTS AND CONCLUSION: Four of the thalidomide embryopathy individuals (13 per cent) had congenital facial palsy. All four had eye aberrations, three had ear anomalies and one had a limb anomaly. Individuals with thalidomide embryopathy without a clinical diagnosis of facial impairment had significantly weaker lips and more restricted lip mobility than healthy controls. This study contributes to the overall knowledge of thalidomide embryopathy by adding a description of how facial expression can be affected in this condition.
BACKGROUND: Earlier studies have shown that individuals with thalidomideembryopathy can have skeletal deformities, ear and eye aberrations, and facial palsy. This study aimed to survey the frequency and characteristics of facial palsy in this group of individuals. PARTICIPANTS: Thirty-one individuals with thalidomideembryopathy (age range, 45-47 years) and 25 healthy adults (age range, 41-56 years; mean age ± standard deviation, 49 ± 4.2 years). MAIN OUTCOME MEASURES: Voluntary facial movements, lip force and three-dimensional lip motion analysis. RESULTS AND CONCLUSION: Four of the thalidomideembryopathy individuals (13 per cent) had congenital facial palsy. All four had eye aberrations, three had ear anomalies and one had a limb anomaly. Individuals with thalidomideembryopathy without a clinical diagnosis of facial impairment had significantly weaker lips and more restricted lip mobility than healthy controls. This study contributes to the overall knowledge of thalidomideembryopathy by adding a description of how facial expression can be affected in this condition.